Birth Defect: Clinical Trials

1 trial for Birth Defect, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Birth Defect: new trials by email Literature Review of Birth Defect trials Research Report on Birth Defect

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission
Tenofovir Disoproxil Fumarate (TDF) 300 mg oral daily. - Hepatitis B Infection, Congenital Malformation
Phase 4UnknownNew Discovery LLC2802018-06-102019-12-12

Narrower conditions

Congenital Abnormalities (1)  ·  Hepatitis B (1)  ·  Persistent Infection (1)  ·  Viremia (1)

Broader conditions

Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  DNA Virus Infections (1)  ·  Digestive System Diseases (1)  ·  Disease Attributes (1)  ·  Hepadnaviridae Infections (1)  ·  Hepatitis (1)  ·  Hepatitis, Viral, Human (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Liver Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sepsis (1)

Interventions

Tenofovir (1)  ·  hepatitis B hyperimmune globulin (1)

Sponsors

New Discovery LLC (1)

Countries

China (1)

Top investigators

Calvin Q Pan, MD (1)  ·  Erhei Dai, MD (1)

Results publications

PMID 39540799